Table 2 Evaluation of MVD rate with clinicopathological features of breast cancer patients
From: CIRBP mRNA level in breast cancer is associated with HIF1α gene expression and microvascular density
Variables | Mean of hot spot/mm2 ± SD | p-value |
|---|---|---|
Tumor size (cm) | ||
< 5 ≥ 5 | 3.157.(± 0.617) 8.478 (± 1.612) | 0.005* |
Grade | ||
I II III | 4.142(± 2.482) 4.150(± 0.932) 9.533(± 2.037) | 0.033* |
Stage | ||
II III | 5.533(± 1.058) 7.416(± 2.359) | 0.002* |
HER2 | ||
Positive Negative | 8.647(± 2.003) 4.320(± 0.875) | 0.060 |
ER | ||
Positive Negative | 6.320(± 1.376) 5.705(± 1.484) | 0.768 |
PR | ||
Positive Negative | 6.391(± 1.444) 5.682(± 1.410) | 0.731 |
P53 | ||
Positive Negative | 4.066(± 1.093) 7.185(± 1.410) | 0.139 |
Necrosis | ||
Yes No | 7.333(± 1.367) 3.800(± 1.211) | 0.060 |
Lymphatic/Vascular invasion | ||
Yes No | 7.038(± 1.367) 4.500(1.387) | 0.224 |